Biostatistics for Phase I–IV Clinical Trials
- Trial design: adaptive, group-sequential, platform, Bayesian, seamless II/III
- Estimands under ICH E9(R1) and intercurrent event strategies
- Sample size, power and simulation of operating characteristics
- Protocol statistics, SAPs, mock shells and missing data strategy
- CSR statistics, ISS/ISE and briefing books for FDA, EMA, PMDA
- Dose-finding (MCP-Mod, BOIN, CRM) and multiplicity strategy